Related Experiment Video
Updated: Jun 10, 2026
07:18
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
ZIC1 overexpression is oncogenic in liposarcoma
Elliott Brill1, Ryan Gobble, Christina Angeles
1Department of Surgery, Computational Biology Center, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Cancer Research
|August 18, 2010
Summary
ZIC1 overexpression drives liposarcoma growth and survival. Targeting ZIC1 may offer a new therapeutic strategy for this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Liposarcomas are aggressive mesenchymal tumors with limited treatment options.
- Current therapies, primarily surgery, are insufficient due to chemoresistance.
- There is a critical need for novel therapeutic targets in liposarcoma.
Purpose of the Study:
- To identify novel genomic alterations in liposarcoma.
- To investigate the role of ZIC1 in liposarcoma pathogenesis.
- To explore ZIC1 as a potential therapeutic target.
Main Methods:
- Gene expression analysis comparing liposarcoma subtypes to normal fat.
- ZIC1 knockdown experiments in liposarcoma cell lines.
- Analysis of downstream target gene expression and protein levels (p27, BCL2L13, JunD, Fam57A, EIF3M).
Main Results:
- ZIC1 is overexpressed across all liposarcoma subtypes.
- ZIC1 knockdown inhibits proliferation, invasion, and induces apoptosis in liposarcoma cells.
- ZIC1 knockdown affects nuclear p27 expression and downregulates prosurvival genes.
Conclusions:
- ZIC1 plays an essential role in liposarcoma development.
- Targeting ZIC1 or its downstream pathways presents a promising therapeutic avenue for liposarcoma.
More Related Videos
Related Concept Videos
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...